To evaluate the effectiveness of ultraviolet-induced fluorescence dermoscopy (UVF-dermoscopy) in differentiating between scarring and nonscarring alopecias.
Approach:
Study Design: A multicentric retrospective observational study analyzing 84 patients with alopecia across five international dermatology centers.
Patient Demographics: Patients included 43 with nonscarring alopecia and 41 with scarring alopecia, categorized by skin phototypes I-III and IV-VI.
Dermoscopy Techniques: Comparison of UVF-dermoscopy and polarized dermoscopy in detecting diagnostic markers for alopecia classification.
Key Findings:
UVF-dermoscopy identified follicular ostia in nonscarring alopecias at a rate of 83.7% compared to 34.9% with polarized dermoscopy (p < 0.01).
Bright white areas were detected in scarring alopecias at 70.7% with UVF-dermoscopy versus 30.1% with polarized dermoscopy (p = 0.01).
In dark skin (phototypes IV-VI), UVF-dermoscopy significantly improved detection of follicular ostia (57.9% vs. 10.5%, p < 0.01), but not bright white areas.
Interobserver agreement for UVF-dermoscopy was higher (Cohen's kappa 0.83) compared to polarized dermoscopy (0.57).
Interpretation:
Limitations:
Retrospective study design.
Lack of dermoscopic-pathological correlation analysis.
Need for further research to validate findings across diverse skin tones and clinical settings.
The sunscreen ingredient, which has been marketed internationally for years, is considered generally recognized as safe and effective for use in adults and pediatric patients aged 6 months and older.
